688428 諾誠健華
按盤價 
23.960 -0.980 (-3.929%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 1,115,328 | 59.85% | 1,009,448 | 738,537 | 625,404 | 1,043,033 | |
| 減：營業總成本 | 1,257,702 | 28.87% | 1,463,013 | 1,377,500 | 1,583,975 | 1,048,443 | |
| 其中:營業成本 | 125,178 | 27.70% | 138,441 | 128,435 | 143,397 | 65,667 | |
| 財務費用 | (74,947) | -49.20% | (93,762) | (68,906) | 171,321 | (188,911) | |
| 資產減值損失 | (169) | -- | (105) | -- | -- | -- | |
| 公允價值變動收益 | 5,095 | -117.32% | (30,462) | (53,963) | 9,953 | (44,281) | |
| 投資收益 | 36,527 | 1,081.69% | 7,117 | 5,572 | (1,225) | (534) | |
| 其中：對聯營企業和合營企業的投資收益 | (698) | -78.60% | (5,260) | (4,900) | (9,711) | (604) | |
| 營業利潤 | (64,690) | -77.32% | (451,049) | (651,154) | (893,202) | (21,461) | |
| 利潤總額 | (64,179) | -77.50% | (452,593) | (644,206) | (893,727) | (20,121) | |
| 減：所得稅費用 | 7,771 | 27,244.40% | 263 | 1,426 | -- | 46,558 | |
| 淨利潤 | (71,951) | -74.78% | (452,856) | (645,632) | (893,727) | (66,679) | |
| 減：非控股權益 | (7,536) | -23.94% | (12,223) | (14,369) | (7,134) | (2,133) | |
| 股東淨利潤 | (64,415) | -76.61% | (440,633) | (631,263) | (886,593) | (64,546) | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.040 | -75.00% | -0.260 | -0.370 | -0.600 | -0.050 | |
| 每股派息 (元) * | -- | -- | -- | -- | -- | -- | |
| 每股淨資產 (元) * | 3.777 | -2.08% | 3.817 | 4.054 | 4.306 | 4.100 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 15/12/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
